Literature DB >> 3666344

Peripheral nerve concentrations of glucose, fructose, sorbitol and myoinositol in diabetic and non-diabetic patients.

P J Hale1, M Nattrass, S H Silverman, C Sennit, C M Perkins, A Uden, G Sundkvist.   

Abstract

Glucose, fructose, sorbitol and myoinositol concentrations were measured in biopsies of peripheral nerve obtained at above-knee or below-knee amputation. In diabetic patients nerve glucose (median [range]) (5.09 [1.62-12.82] vs 3.12 [1.81-4.01]) p less than 0.001, fructose (0.245 [0.060-1.280] vs 0.150 [0.053-0.385]) p less than 0.05, and sorbitol (0.028 [0.012-0.496] vs 0.016 [0.007-0.059] p less than 0.02, mumol/g wet weight) were significantly higher than in non-diabetic patients. No significant difference was found in myoinositol concentration (1.95 [1.00-3.55] vs 2.09 [1.27-5.40] mumol/g wet weight). Concentrations differed markedly from previously reported values in human nerve obtained at post-mortem.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3666344     DOI: 10.1007/bf00279613

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Effect of blood sugar control on the accumulation of sorbitol and fructose in nervous tissues.

Authors:  J D Ward; R W Baker; B H Davis
Journal:  Diabetes       Date:  1972-12       Impact factor: 9.461

2.  Quantitative determination of mixtures of monosaccharides, disaccharides and alditols as their trimethylsilyl ether derivatives by gas-liquid chromatography.

Authors:  J De Neef
Journal:  Clin Chim Acta       Date:  1969-12       Impact factor: 3.786

Review 3.  The biochemistry of the complications of diabetes mellitus.

Authors:  M Brownlee; A Cerami
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 4.  Hyperglycemia, polyol metabolism, and complications of diabetes mellitus.

Authors:  K H Gabbay
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

5.  Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.

Authors:  K R Gillon; J N Hawthorne; D R Tomlinson
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

6.  Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes.

Authors:  K P Palmano; P H Whiting; J N Hawthorne
Journal:  Biochem J       Date:  1977-10-01       Impact factor: 3.857

7.  Nerve lipid abnormalities in human diabetic neuropathy: a correlative study.

Authors:  M J Brown; M Iwamori; Y Kishimoto; B Rapoport; H W Moser; A K Asbury
Journal:  Ann Neurol       Date:  1979-03       Impact factor: 10.422

8.  Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.

Authors:  D Stribling; D J Mirrlees; H E Harrison; D C Earl
Journal:  Metabolism       Date:  1985-04       Impact factor: 8.694

9.  Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.

Authors:  P J Dyck; W R Sherman; L M Hallcher; F J Service; P C O'Brien; L A Grina; P J Palumbo; C J Swanson
Journal:  Ann Neurol       Date:  1980-12       Impact factor: 10.422

10.  Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.

Authors:  D R Tomlinson; R J Moriarty; J H Mayer
Journal:  Diabetes       Date:  1984-05       Impact factor: 9.461

View more
  5 in total

1.  Endoneurial capillary abnormalities in mild human diabetic neuropathy.

Authors:  R A Malik; A Veves; E A Masson; A K Sharma; A K Ah-See; W Schady; R H Lye; A J Boulton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 2.  Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence.

Authors:  E A Masson; A J Boulton
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy.

Authors:  R A Malik; P G Newrick; A K Sharma; A Jennings; A K Ah-See; T M Mayhew; J Jakubowski; A J Boulton; J D Ward
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

4.  The effect of high glucose on polyol pathway activity and myoinositol metabolism in cultured human endothelial cells.

Authors:  G C Hawthorne; K Bartlett; C S Hetherington; K G Alberti
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

5.  Hypoxic neuropathy: relevance to human diabetic neuropathy.

Authors:  R A Malik; E A Masson; A K Sharma; R H Lye; A K Ah-See; A M Compton; D R Tomlinson; S P Hanley; A J Boulton
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.